Rio-Vilariño, A., Cenigaonandia-Campillo, A., García-Bautista, A., Mateos-Gómez, P. A., Schlaepfer, M. I., del Puerto-Nevado, L., Aguilera, O., García-García, L., Galeano, C., de Miguel, I., Serrano-López, J., Baños, N., Fernández-Aceñero, M. J., Lacal, J. C., Medico, E., García-Foncillas, J., & Cebrián, A. (2024). Correction to: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells (British Journal of Cancer, (2024), 130, 8, (1402-1413), 10.1038/s41416-024-02649-z). En British Journal of Cancer (Vol. 130, Número 8, p. 1414). Springer Nature. https://doi.org/10.1038/S41416-024-02667-X